News & events
Brenda Ogle named BMES fellow
Posted
She was selected for her achievements in 3D bioprinting for cardiac tissue engineering, yielding a chambered heart organoid, as well as leadership and service to the BME field including diversity, equity, and inclusivity.
BME researchers help validate microchip sensor featured on the cover of Science Advances
Posted
The technology could give patients a rapid and low cost way to monitor their hormone levels and better manage chronic inflammation, stress, and other conditions.
NIH recognizes UMN senior design team for biomedical engineering solution
Posted
A team of BME seniors designed DuoPouch, a calibrated, two-pouch system to diagnose postpartum hemorrhage.
Jules Anh Tuan Nguyen receives UMN-wide Best Dissertation Award
Posted
The Graduate School has announced Jules Anh Tuan Nguyen has been named a winner of the 2021 Best Dissertation Award, for the physical sciences and engineering category.
PhD student Malaney Young successfully defends dissertation
Posted
Her dissertation is titled, "Targeting Death Receptor 5 for Therapeutic Discovery."
New BME study provides clues to decades-old mystery about cell movement
Posted
The game-changing discovery impacts tissue engineering, wound healing, and cancer research.
BME researchers identify potential therapeutic target for treating sickle cell disease
Posted
New research shows methionine aminopeptidase 2 (MetAP2) inhibitors could be a therapeutic target for treating sickle cell disease.
Gabbi Horsford named DEI Coordinator
Posted
Gabbi brings a wealth of experience in anti-racism education and strategy development, as well as a passion for policy interventions and DEI initiatives.
Prof. Opitz receives nearly $7 million to advance brain stimulation technologies
Posted
Funding is supporting Prof. Opitz’s efforts to better understand the mechanisms of widely used brain stimulation methods and develop improved applications.
Prof. Sachs secures more than $6 million to advance molecular therapeutics
Posted
An infusion of new funds will help advance scientists’ understanding of molecular dynamics and develop new drugs for treating neurodegenerative diseases, including Alzheimer’s and Parkinson’s, and inflammatory conditions such as rheumatoid arthritis.